Unveiling Growth Trajectory: Breast Implants Market Forecast With A CAGR Of 7.8% By 2030
Breast Implants Market Size Was Valued at USD 1.76 Billion in 2022 and is Projected to Reach USD 3.21 Billion by 2030, Growing at a CAGR of 7.8% From 2023-2030.
The breast implants market is a significant segment within the global cosmetic surgery industry, focused on the surgical enhancement of breast size and shape through the use of implants. Breast implants are medical devices typically made of silicone gel or saline solution encased in a silicone shell, and they are used in breast augmentation, breast reconstruction, and breast revision surgeries. The market caters to individuals seeking aesthetic improvement, breast asymmetry correction, or reconstruction following mastectomy or breast cancer treatment. With the increasing acceptance of cosmetic procedures, advancements in implant technology, and growing consumer awareness about body aesthetics, the breast implants market continues to evolve and expand globally.
Key Companies Profiled:
Mentor Worldwide LLC (U.S.),Sientra Inc. (U.S.),Johnson & Johnson (U.S.),Ideal Implant Incorporated (U.S.),RTI Surgical Inc. (U.S.),Zimmer Biomet Holdings, Inc. (U.S.),Establishment Labs Holdings Inc. (U.S.),Allergan (Ireland),GC Aesthetics (Ireland),Polytech Health & Aesthetics GmbH (Germany),Sebbin SAS (France),Arion Laboratories (France),Groupe Sebbin SAS (France),CEREPLAS (France),Laboratoires Arion (France),POLYTECH Health & Aesthetics GmbH (Germany),Hans Biomed Co. Ltd. (South Korea),Shanghai Kangning Medical Supplies Ltd. (China),G&G Biotechnology Ltd. (China),Guangzhou Wanhe Plastic Materials Co., Ltd. (China),Shanghai Kangning Medical Device Co., Ltd. (China),Wanhe Plastic Materials Co., Ltd. (China).
Request Sample PDF Copy at:
https://introspectivemarke...